Navigation Links
MannKind Corporation Reports Second Quarter Financial Results
Date:8/11/2008

- Conference Call Today at 5:00 p.m. EDT -

VALENCIA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD) today reported financial results for the second quarter ended June 30, 2008.

For the second quarter of 2008, total operating expenses were $80.9 million, compared to $75.4 million for the second quarter of 2007. This increase was primarily attributable to increased research and development (R&D) expenses which totaled $67.6 million for this quarter compared to $61.5 million for the same quarter in 2007. The increase in research and development expenses for the three months ended June 30, 2008 as compared to the same period in the prior year was primarily due to increases in manufacturing costs, clinical trial costs, and stock-based compensation expense. General and administrative (G&A) expenses decreased by $0.6 million to $13.3 million for the second quarter of 2008 compared to the second quarter of 2007. The decrease in general and administrative expenses for the three months ended June 30, 2008 as compared to the same period in the prior year was primarily due to lower professional service fees, partially offset by increases in stock-based compensation expense and salary related expenses.

For the first six months of 2008, operating expenses totaled $154.9 million, compared to $152.7 million in the first half of 2007. R&D expenses for the first six months were $126.0 million, compared to $125.3 million in 2007. The increase in R&D expenses for the first six months was primarily due to increases in stock-based compensation expense and manufacturing costs, partially offset by lower clinical trial costs. G&A expenses increased by $1.5 million to $28.9 million for the first half
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
2. MannKind to Present at Upcoming Conferences
3. MannKind Corporation Reports First Quarter Financial Results
4. MannKind to Present at the Morgan Stanley Healthcare Conference
5. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
6. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
7. MannKind Corporation Response to Recent Market Events
8. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
9. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
10. MannKind to Present at the Wachovia 2008 Healthcare Conference
11. MannKind to Present at the Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2013)... 2013) Synthetic, man-made cells and ultrathin electronics ... nanotube may be possible through research at the ... research, ""Zero-Dimensional" Single-Walled Carbon Nanotubes," was published in ... investigators are Steven R. Little, PhD, associate professor, ... of Chemical and Petroleum Engineering; and Anna C. ...
(Date:12/11/2013)... 2103 -- Figuring that if some is good, ... to pack more graphene, a supermaterial, into structural ... materials engineers discovered that, in this case, less ... Dzenis, McBroom professor of mechanical and materials engineering ... Materials and Nanoscience, learned that using a small ...
(Date:12/11/2013)... 11, 2013 Convey Computer™ ... Convey’s expanding bioinformatics suite, PacBioToCA, an application that ... Pacific Biosciences ® long-read technology. Optimized to take ... the Convey hybrid-core (HC) server, PacBioToCA delivers six ... on Convey HC systems for sequencing and assembly ...
(Date:12/11/2013)... CA (PRWEB) December 11, 2013 ... cancer treatment and management through the genomic analysis ... multi-year agreement with CollabRx, Inc., a data analytics ... molecular medicine, to offer clinical actionable reports built ... genomic tests. , Under this agreement, Cynvenio will ...
Breaking Biology Technology:Countdown to zero: New 'zero-dimensional' carbon nanotube may lead to superthin electronics and synt 2UNL-led team finds less is more with adding graphene to nanofibers 2Convey Computer’s Implementation of PacBioToCA Algorithm Speeds DNA Sequence Assembly, Delivering Up to Fifteen Times Acceleration 2Convey Computer’s Implementation of PacBioToCA Algorithm Speeds DNA Sequence Assembly, Delivering Up to Fifteen Times Acceleration 3Cynvenio and CollabRx Announce Partnership for Cancer Molecular Diagnostics 2Cynvenio and CollabRx Announce Partnership for Cancer Molecular Diagnostics 3
... Mass., Nov. 26 Coley,Pharmaceutical Group, Inc. (Nasdaq: ... Ph.D., President & Chief Executive Officer, will be ... Markets Fourth Annual,Healthcare Conference at 10:00am ET on ... Interested parties may access an audio webcast ...
... ANGELES, Nov. 26 Signalife, Inc. (Amex:,SGN - ... and sell - without,prescription - its ambulatory event ... will market as the Fidelity 200 HeartLife,Tempo Card, ... monitoring device which will be used as an ...
... LAKE CITY, Nov. 26 Amedica Corporation, an,orthopedic ... today that the U.S. Food and Drug Administration,has ... Screw,system., The Valeo Pedicle Screw system is ... features that are aimed at allowing surgeons,greater flexibility ...
Cached Biology Technology:Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference 2Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device 2Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device 3Amedica Receives FDA 510(k) Clearance for Valeo(TM) Pedicle Screw System 2
(Date:12/12/2013)... a scientist from Case Western Reserve University, have announced ... from 4.4 million-year-old fossil-rich deposits in Ethiopia. ... zebra, Eurygnathohippus woldegabrieli named for geologist Giday WoldeGabriel, ... 1987had three-toed hooves and grazed the grasslands and shrubby ... They report their findings in the November issue of ...
(Date:12/12/2013)... insects in passing has been discovered to target its ... by scientists at Queen Mary University of London. ... the Pallas long-tongued bat use echolocation a complex ... processing of ultrasonic pulses for detecting unseen obstacles or ... of echolocation pulses to attack their prey and many ...
(Date:12/12/2013)... lot about the way species evolve after they move ... broad study conducted in part by Florida State University ... of the evolutionary history of rodents calls into doubt ... a new region, such as a continent, evolution leads ... of species. , "Biological diversification, or adaptive radiation, is ...
Breaking Biology News(10 mins):A new species of horse, 4.4 million years old 2A new species of horse, 4.4 million years old 3Stealth maneuver allows nectar bats to target insect prey 2Study of rodent family tree puts brakes on commonly held understanding of evolution 2Study of rodent family tree puts brakes on commonly held understanding of evolution 3
... hibernation hormone in the brain may unlock the mystery ... 7, 2006 issue of Cell. Hibernation allows animals from ... suspended animation--under the harshest of winter conditions. , If ... represent the first essential brain signal governing the seasonal ...
... supplement L-arginine following a heart attack does not improve ... with an increased risk of death, according to a ... L-arginine is a widely available dietary supplement and is ... heart failure and sexual dysfunction, according to background information ...
... could help control an invasive mollusk that has ravaged ... virtually wiping out some native mussels species and causing ... which contain toxins that dissolve within a zebra mussel's ... eliminating one of the world's "most important economic pests" ...
Cached Biology News:Possible brain hormone may unlock mystery of hibernation 2Possible brain hormone may unlock mystery of hibernation 3Use of amino acid supplement following a heart attack provides no benefit, may be harmful 2'Biobullets' fight harmful mussels 2
Human MFRP MAb (Clone 291218)...
Human RELT/TNFRSF19L MAb (Clone 238104)...
...
... kit measures NOS activity by monitoring the ... assay is simple, sensitive, and specific for ... both crude and purified enzyme preparations. The ... 50 total reactions. Radiolabeled arginine and NADPH ...
Biology Products: